These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 15514207)

  • 21. Raman spectroscopic evaluation of the effects of diet and lipid-lowering therapy on atherosclerotic plaque development in mice.
    van De Poll SW; Römer TJ; Volger OL; Delsing DJ; Bakker Schut TC; Princen HM; Havekes LM; Jukema JW; van Der Laarse A; Puppels GJ
    Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1630-5. PubMed ID: 11597937
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis.
    Kuryata OV; Yegorova YV
    Kardiol Pol; 2006 Jan; 64(1):44-8; discussion 49-50. PubMed ID: 16444629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice.
    Trion A; de Maat MP; Jukema JW; van der Laarse A; Maas MC; Offerman EH; Havekes LM; Szalai AJ; Princen HM; Emeis JJ
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1635-40. PubMed ID: 15920036
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effects of amlodipine and atorvastatin treatment and their combination on atherosclerosis in ApoE*3-Leiden transgenic mice.
    Delsing DJ; Jukema JW; van de Wiel MA; Emeis JJ; van der Laarse A; Havekes LM; Princen HM
    J Cardiovasc Pharmacol; 2003 Jul; 42(1):63-70. PubMed ID: 12827028
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The comparison of the effects of standard 20 mg atorvastatin daily and 20 mg atorvastatin every other day on serum LDL-cholesterol and high sensitive C-reactive protein levels.
    Keleş T; Akar Bayram N; Kayhan T; Canbay A; Sahin D; Durmaz T; Ozdemir O; Aydoğdu S; Diker E
    Anadolu Kardiyol Derg; 2008 Dec; 8(6):407-12. PubMed ID: 19103535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
    Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endothelial overexpression of Fas ligand decreases atherosclerosis in apolipoprotein E-deficient mice.
    Yang J; Sato K; Aprahamian T; Brown NJ; Hutcheson J; Bialik A; Perlman H; Walsh K
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1466-73. PubMed ID: 15178561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apolipoprotein E promotes the regression of atherosclerosis independently of lowering plasma cholesterol levels.
    Raffai RL; Loeb SM; Weisgraber KH
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):436-41. PubMed ID: 15591220
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE*3Leiden.CETP transgenic mice with or without treatment with atorvastatin.
    Kühnast S; van der Hoorn JW; van den Hoek AM; Havekes LM; Liau G; Jukema JW; Princen HM
    J Hypertens; 2012 Jan; 30(1):107-16. PubMed ID: 22134386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice.
    Paul A; Ko KW; Li L; Yechoor V; McCrory MA; Szalai AJ; Chan L
    Circulation; 2004 Feb; 109(5):647-55. PubMed ID: 14744975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Murine cytomegalovirus infection increases aortic expression of proatherosclerotic genes.
    Burnett MS; Durrani S; Stabile E; Saji M; Lee CW; Kinnaird TD; Hoffman EP; Epstein SE
    Circulation; 2004 Feb; 109(7):893-7. PubMed ID: 14757699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Raman spectroscopic investigation of atorvastatin, amlodipine, and both on atherosclerotic plaque development in APOE*3 Leiden transgenic mice.
    van de Poll SW; Delsing DJ; Jukema JW; Princen HM; Havekes LM; Puppels GJ; van der Laarse A
    Atherosclerosis; 2002 Sep; 164(1):65-71. PubMed ID: 12119194
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Olmesartan and pravastatin additively reduce development of atherosclerosis in APOE*3Leiden transgenic mice.
    van der Hoorn JW; Kleemann R; Havekes LM; Kooistra T; Princen HM; Jukema JW
    J Hypertens; 2007 Dec; 25(12):2454-62. PubMed ID: 17984667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Osteoarthritis development is induced by increased dietary cholesterol and can be inhibited by atorvastatin in APOE*3Leiden.CETP mice--a translational model for atherosclerosis.
    Gierman LM; Kühnast S; Koudijs A; Pieterman EJ; Kloppenburg M; van Osch GJ; Stojanovic-Susulic V; Huizinga TW; Princen HM; Zuurmond AM
    Ann Rheum Dis; 2014 May; 73(5):921-7. PubMed ID: 23625977
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endothelin-mediated vasoconstriction in early atherosclerosis is markedly increased in ApoE-/- mouse but prevented by atorvastatin.
    Maguire JJ; Wiley KE; Kuc RE; Stoneman VE; Bennett MR; Davenport AP
    Exp Biol Med (Maywood); 2006 Jun; 231(6):806-12. PubMed ID: 16741003
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-inflammatory salicylate beneficially modulates pre-existing atherosclerosis through quenching of NF-κB activity and lowering of cholesterol.
    de Vries-van der Weij J; Toet K; Zadelaar S; Wielinga PY; Kleemann R; Rensen PC; Kooistra T
    Atherosclerosis; 2010 Nov; 213(1):241-6. PubMed ID: 20926077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-atherosclerotic effect of amlodipine, alone and in combination with atorvastatin, in APOE*3-Leiden/hCRP transgenic mice.
    Trion A; de Maat M; Jukema W; Maas A; Offerman E; Havekes L; Szalai A; van der Laarse A; Princen H; Emeis J
    J Cardiovasc Pharmacol; 2006 Jan; 47(1):89-95. PubMed ID: 16424791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-1 plays a major role in vascular inflammation and atherosclerosis in male apolipoprotein E-knockout mice.
    Merhi-Soussi F; Kwak BR; Magne D; Chadjichristos C; Berti M; Pelli G; James RW; Mach F; Gabay C
    Cardiovasc Res; 2005 Jun; 66(3):583-93. PubMed ID: 15914123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer?
    Reifenberg K; Lehr HA; Baskal D; Wiese E; Schaefer SC; Black S; Samols D; Torzewski M; Lackner KJ; Husmann M; Blettner M; Bhakdi S
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1641-6. PubMed ID: 15920030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atorvastatin inhibits the 5-lipoxygenase pathway and expression of CCL3 to alleviate atherosclerotic lesions in atherosclerotic ApoE knockout mice.
    Yang LX; Heng XH; Guo RW; Si YK; Qi F; Zhou XB
    J Cardiovasc Pharmacol; 2013 Aug; 62(2):205-11. PubMed ID: 23615158
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.